| Tue, Nov 24, 2009 | | | 4 Platform Drugmakers to Invest In at Motley Fool (Tue, Nov 24)
| | Fri, Nov 20, 2009 | | | UPDATE - HealthCor slams Biogen CEO for outsize pay package at Reuters (Fri, Nov 20)
| | Thu, Nov 12, 2009 | | | Thursday Options Recap at Seeking Alpha (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | | When Rival Drug Makers Compare Notes On Safety Problems at The Wall Street Journal Online (Wed, Nov 11)
| | | Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09) at Seeking Alpha (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | | Lightning Round: Priceline.com, Citigroup, Transocean and More at CNBC (Tue, Nov 10)
| | | Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference Business Wire (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | | Successful Pharmaceutical Company Mergers: Abbott Labs Is Leader Wall Street Transcript (Mon, Nov 9)
| | | A Bear in the Bullpen: 3 Power Ratings Stocks Ready to Drop TradingMarkets.com (Mon, Nov 9)
| | Sat, Nov 7, 2009 | | | Elan, Biogen change Tysabri label due to PML risk at Reuters (Sat, Nov 7)
| | Tue, Nov 3, 2009 | | | Nice Quarter, Teva. What Will You Buy Next? at Motley Fool (Tue, Nov 3)
| | | UPDATE - J&J slashing workforce, cites cost of drug research at Reuters (Tue, Nov 3)
| | | Johnson & Johnson to cut up to 8,200 jobs at MarketWatch (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | | Healthcare Earnings Are Coming Into Focus at Investopedia (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | | Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011 Business Wire (Thu, Oct 29)
| | | 3 Stocks in a Tailspin at Motley Fool (Thu, Oct 29)
| | | UPDATE - EU agency reports 24th case of Tysabri infection at Reuters (Thu, Oct 29)
| | | 5-Star Stocks Poised to Pop: MEMC at Motley Fool (Thu, Oct 29)
| | | More PML Troubles for Biogen, Elan MS Drug: Biobuzz at TheStreet.com (Thu, Oct 29)
| | | Elan downgraded by UBS Briefing.com (Thu, Oct 29)
| Add ELN News to My Yahoo!:

| |
|